目的 回顾性分析自身免疫性胰腺炎(AIP)患者及胰腺癌患者的临床症状及血清学特征,提高AIP与胰腺癌的鉴别诊断能力.方法 选取2003年1月至2011年10月我院外科收治的术后病理学结果符合亚洲标准的AIP患者36例及支持胰腺癌组织病理学诊断的患者95例,总结AIP与胰腺癌在临床症状、血清学等方面鉴别诊断的特点.结果 AIP与胰腺癌的鉴别特征:(1)胰腺癌患者年龄(60.9±9.0)岁高于AIP患者(53.56±14.6)岁(t=3.48,P<0.05),AIP更倾向于男性(x2=2.88,P<0.05);(2)AIP与胰腺癌的临床特征极易混淆,均有年龄特点,表现为低年龄症状相对典型,易早期发现,高年龄相对隐匿,易导致延误.(3) AIP更易合并胆系炎症(47.2%与12.6%,x2=18.12,P<0.05),胰腺癌更易合并肝肾囊肿(29.5%与0,x2=13.50,P<0.05);(4)高滴度CA199在诊断胰腺癌方面具有较高的价值[浓度:AIP组:20.51 (9.55,86.50) kU/L,胰腺癌组:326.50(94.38,10 393.00) kU/L;阳性率:AIP组:35.70% (10/28),胰腺癌组:86.70%(65/75),P=0.000].高滴度淀粉酶[浓度:AIP组:103.50(72.00,252.00) U/L,胰腺癌组:46.50(21.65,96.90) U/L;阳性率:AIP组:45.00% (9/20),胰腺癌组:19.40% (7/36),P=0.043]、脂肪酶[浓度:AIP组:340.50(152.05,495.80) U/L,胰腺癌组:107.40(23.40,177.26) U/L,P=0.005]、天冬氨酸氨基转移酶[阳性率:AIP组:75.00% (27/36),胰腺癌组:55.90% (52/93),P=0.046]、γ-谷氨酰转肽酶[阳性率:AIP组:79.40%(27/34),胰腺癌组:57.10%(52/91),P=0.022]在诊断AIP方面具有较高的价值,CA199明显升高不是除外AIP的依据.结论 AIP做为一种特殊类型的慢性胰腺炎,在临床症状及血清学方面可与胰腺癌进行鉴别诊断.
目的 迴顧性分析自身免疫性胰腺炎(AIP)患者及胰腺癌患者的臨床癥狀及血清學特徵,提高AIP與胰腺癌的鑒彆診斷能力.方法 選取2003年1月至2011年10月我院外科收治的術後病理學結果符閤亞洲標準的AIP患者36例及支持胰腺癌組織病理學診斷的患者95例,總結AIP與胰腺癌在臨床癥狀、血清學等方麵鑒彆診斷的特點.結果 AIP與胰腺癌的鑒彆特徵:(1)胰腺癌患者年齡(60.9±9.0)歲高于AIP患者(53.56±14.6)歲(t=3.48,P<0.05),AIP更傾嚮于男性(x2=2.88,P<0.05);(2)AIP與胰腺癌的臨床特徵極易混淆,均有年齡特點,錶現為低年齡癥狀相對典型,易早期髮現,高年齡相對隱匿,易導緻延誤.(3) AIP更易閤併膽繫炎癥(47.2%與12.6%,x2=18.12,P<0.05),胰腺癌更易閤併肝腎囊腫(29.5%與0,x2=13.50,P<0.05);(4)高滴度CA199在診斷胰腺癌方麵具有較高的價值[濃度:AIP組:20.51 (9.55,86.50) kU/L,胰腺癌組:326.50(94.38,10 393.00) kU/L;暘性率:AIP組:35.70% (10/28),胰腺癌組:86.70%(65/75),P=0.000].高滴度澱粉酶[濃度:AIP組:103.50(72.00,252.00) U/L,胰腺癌組:46.50(21.65,96.90) U/L;暘性率:AIP組:45.00% (9/20),胰腺癌組:19.40% (7/36),P=0.043]、脂肪酶[濃度:AIP組:340.50(152.05,495.80) U/L,胰腺癌組:107.40(23.40,177.26) U/L,P=0.005]、天鼕氨痠氨基轉移酶[暘性率:AIP組:75.00% (27/36),胰腺癌組:55.90% (52/93),P=0.046]、γ-穀氨酰轉肽酶[暘性率:AIP組:79.40%(27/34),胰腺癌組:57.10%(52/91),P=0.022]在診斷AIP方麵具有較高的價值,CA199明顯升高不是除外AIP的依據.結論 AIP做為一種特殊類型的慢性胰腺炎,在臨床癥狀及血清學方麵可與胰腺癌進行鑒彆診斷.
목적 회고성분석자신면역성이선염(AIP)환자급이선암환자적림상증상급혈청학특정,제고AIP여이선암적감별진단능력.방법 선취2003년1월지2011년10월아원외과수치적술후병이학결과부합아주표준적AIP환자36례급지지이선암조직병이학진단적환자95례,총결AIP여이선암재림상증상、혈청학등방면감별진단적특점.결과 AIP여이선암적감별특정:(1)이선암환자년령(60.9±9.0)세고우AIP환자(53.56±14.6)세(t=3.48,P<0.05),AIP경경향우남성(x2=2.88,P<0.05);(2)AIP여이선암적림상특정겁역혼효,균유년령특점,표현위저년령증상상대전형,역조기발현,고년령상대은닉,역도치연오.(3) AIP경역합병담계염증(47.2%여12.6%,x2=18.12,P<0.05),이선암경역합병간신낭종(29.5%여0,x2=13.50,P<0.05);(4)고적도CA199재진단이선암방면구유교고적개치[농도:AIP조:20.51 (9.55,86.50) kU/L,이선암조:326.50(94.38,10 393.00) kU/L;양성솔:AIP조:35.70% (10/28),이선암조:86.70%(65/75),P=0.000].고적도정분매[농도:AIP조:103.50(72.00,252.00) U/L,이선암조:46.50(21.65,96.90) U/L;양성솔:AIP조:45.00% (9/20),이선암조:19.40% (7/36),P=0.043]、지방매[농도:AIP조:340.50(152.05,495.80) U/L,이선암조:107.40(23.40,177.26) U/L,P=0.005]、천동안산안기전이매[양성솔:AIP조:75.00% (27/36),이선암조:55.90% (52/93),P=0.046]、γ-곡안선전태매[양성솔:AIP조:79.40%(27/34),이선암조:57.10%(52/91),P=0.022]재진단AIP방면구유교고적개치,CA199명현승고불시제외AIP적의거.결론 AIP주위일충특수류형적만성이선염,재림상증상급혈청학방면가여이선암진행감별진단.
Objective To improve the different diagnosis between autoimmune pancreatitis(AIP) and pancreatic cancer(PC) by a retrospective analysis of clinical symptoms and serological features.Methods The analysis included 36 patients who had postoperative pathological,serological findings consistent with Asian AIP standards and 95 patients who had postoperative pathological consistent with PC pathological standards.All patients were admitted by the surgery department of our hospital from January,2003 to October,2011.A retrospective comparative analysis of the clinical manifestations,serology data of these AIP and PC patients was conducted.And summary the differential diagnosis characteristics of AIP and pancreatic cancer in the clinical symptoms,the serology.Results The features of different diagnosis:(1) The age of patients with PC was higher than AIP((60.9 ±9.0) years vs.(53.56 ± 14.6) years,t =3.48,P <0.05),and AIP preferred to male groups (x2 =2.88,P =0.09).(2) The clinical features of AlP and PC with the age characteristics were easily confused.Both clinical features were relatively typical in younger age which could be found earlier and relatively insidious in the older age which might be found with delay.(3) AIP were often complicated by biliary system inflammations(AIP =47.2%,PC =12.6%,x2 =18.12,P < 0.05),while PC were usually complicated by the cysts in liver and kidney (PC =29.5%,AIP =0,x2 =13.50,P < 0.05).(4) The high titer in CA199 had a higher value in the diagnosis of PC (concentration:group AIP =20.51 (9.55,86.5) kU/L,group PC =326.50 (94.38,10393.00) kU/L; positive rate:group AIP =35.70% (10/28),group PC =86.70% (65/75),P =0.000).The high titers in amylase (concentration:group AIP =103.50 (72.00,252.00) U/L,group PC =46.50 (21.65,96.90) U/L; positive rate:group AIP =45.00% (9/20),group PC =19.40% (7/36),P =0.043),lipase(concentration:group AIP =340.50(152.05,495.80) U/L,group PC =107.40(23.40,177.26) U/L,P =0.005 ; aspartate aminotransferase (positive rate:group AIP =75.00% (27/36),group,PC =55.90% (52/93),P =0.046) andγ-glutamyltranspeptidase (positive rate:group AIP =79.40% (27/34),group PC =57.10% (52/91),P =0.022) had higher values in the diagnosis of AIP.The significant increases in CA199 were not the basis which excluding AIP.Conclusion AIP as a unique type of chronic pancreatitis can be distinguished from PC on distinctive clinical,serological characteristics.